How do I install the Endo Against 25ohd Test Obesity skill?

Run npx skillmds@latest add dromlakhani/endo-against-25ohd-test-obesity in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Endo Against 25ohd Test Obesity safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: makes network calls. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Endo Against 25ohd Test Obesity?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Endo Against 25ohd Test Obesity free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Endo Against 25ohd Test Obesity?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Endo Against 25ohd Test Obesity by dromlakhani

Name: Endo Against 25ohd Test Obesity
Rating: 4.666666666666667 (3 reviews)
Author: dromlakhani

Endo Against 25ohd Test Obesity

Recommends against routine screening for 25(OH)D levels in adults with obesity (BMI ≥30 kg/m²). Use when a clinician considers ordering a 25(OH)D test for an obese patient without established indications for vitamin D testing.

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

Against routine 25(OH)D testing in adults with obesity

STEP 1 — Gather Information

Measure BMI and assess for established indications for 25(OH)D testing (e.g., hypocalcemia, malabsorption syndromes, renal osteodystrophy, hepatogenic osteoporosis, or symptoms such as bone pain, proximal muscle weakness, unexplained fractures). Document absence of these indications.

STEP 2 — Rule In / Rule Out

If BMI ≥30 kg/m² and no established indication for 25(OH)D testing → proceed to Step 3 (classify as obese without indication). Otherwise → consider 25(OH)D testing per the identified indication and stop using this skill.

STEP 3 — Classify or Stratify

Classify the patient as an adult with obesity (BMI ≥30 kg/m²) lacking established indications for 25(OH)D testing.

STEP 4 — Decide

Recommend against routine 25(OH)D testing; do not order the test solely based on obesity. If vitamin D repletion is clinically indicated for other reasons (e.g., osteoporosis, falls, known deficiency symptoms), follow condition‑specific guidance without relying on a 25(OH)D level.

Clinical Guardrails / Mimics / Pitfalls

Do not use obesity alone as a trigger for 25(OH)D testing; avoid interpreting low 25(OH)D levels in obesity as requiring repletion without established benefit thresholds. Do not delay empiric vitamin D for proven indications (e.g., treatment of osteoporosis) pending a test result. Recognize that 25(OH)D assays vary and obesity‑related sequestration does not define a therapeutic target.

Concrete Clinical Example

A 52‑year‑old woman with BMI 34 kg/m² requests a vitamin D level check during a wellness visit. She denies hypocalcemia, malabsorption, bone pain, or fractures. Applying the skill: BMI ≥30 kg/m² and no established indication → recommend against routine 25(OH)D testing.

Source: Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, https://doi.org/10.1210/clinem/dgae290

---name: endo-against-25ohd-test-obesitydescription: Recommends against routine screening for 25(OH)D levels in adults with obesity (BMI ≥30 kg/m²). Use when a clinician considers ordering a 25(OH)D test for an obese patient without established indications for vitamin D testing.---# Against routine 25(OH)D testing in adults with obesity## STEP 1 — Gather InformationMeasure BMI and assess for established indications for 25(OH)D testing (e.g., hypocalcemia, malabsorption syndromes, renal osteodystrophy, hepatogenic osteoporosis, or symptoms such as bone pain, proximal muscle weakness, unexplained fractures). Document absence of these indications.## STEP 2 — Rule In / Rule OutIf BMI ≥30 kg/m² **and** no established indication for 25(OH)D testing → proceed to Step 3 (classify as obese without indication). Otherwise → consider 25(OH)D testing per the identified indication and stop using this skill.## STEP 3 — Classify or StratifyClassify the patient as an adult with obesity (BMI ≥30 kg/m²) lacking established indications for 25(OH)D testing.## STEP 4 — DecideRecommend against routine 25(OH)D testing; do not order the test solely based on obesity. If vitamin D repletion is clinically indicated for other reasons (e.g., osteoporosis, falls, known deficiency symptoms), follow condition‑specific guidance without relying on a 25(OH)D level.## Clinical Guardrails / Mimics / PitfallsDo not use obesity alone as a trigger for 25(OH)D testing; avoid interpreting low 25(OH)D levels in obesity as requiring repletion without established benefit thresholds. Do not delay empiric vitamin D for proven indications (e.g., treatment of osteoporosis) pending a test result. Recognize that 25(OH)D assays vary and obesity‑related sequestration does not define a therapeutic target.## Concrete Clinical ExampleA 52‑year‑old woman with BMI 34 kg/m² requests a vitamin D level check during a wellness visit. She denies hypocalcemia, malabsorption, bone pain, or fractures. Applying the skill: BMI ≥30 kg/m² and no established indication → recommend against routine 25(OH)D testing.**Source:** Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, https://doi.org/10.1210/clinem/dgae290

Frequently asked questions